-
Mashup Score: 2In stark reversal, FDA to reconsider removal of Eli Lilly weight loss drug from shortage list - 1 month(s) ago
The FDA, in a stark reversal, on Friday said it would reconsider its decision to remove Eli Lilly’s tirzepatide, from its shortage list.
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 2In stark reversal, FDA to reconsider removal of Eli Lilly weight loss drug from shortage list - 1 month(s) ago
The FDA, in a stark reversal, on Friday said it would reconsider its decision to remove Eli Lilly’s tirzepatide, from its shortage list.
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Mount Sinai, Noom partner to enhance weight loss care - 2 month(s) ago
“Discover a new collaboration between Mount Sinai Health System and Noom, providing patients with on-demand tools and resources for healthy weight loss goals. L
Source: www.beckershospitalreview.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Weight-loss drugs are supposed to be forever. Until they run out. - 2 month(s) ago
Doctors and patients struggle with starting and stopping medications with little guidance.
Source: www.washingtonpost.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 9DBL's HOUSE CALL: Weight Loss Drugs - 3 month(s) ago
Don’t miss the special edition on @DailyBlastLIVE ‘s HOUSE CALLS! I’m breaking down everything you need to know about weight loss drugs—what works, what’s ri…
Source: www.youtube.comCategories: General Medicine News, Expert PicksTweet
-
Mashup Score: 0Noom partners with Zumba for dance instructors to become Mindset - 3 month(s) ago
Zumba’s fitness instructors will be trained in Noom’s psychology and human coaching methodologies and be behavioral change coaches on Noom.
Source: www.mobihealthnews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 1Gender-sensitive community weight-loss programmes to address overweight and obesity in men: a scoping review - 4 month(s) ago
Objectives To examine how gender-sensitive community weight-loss programmes have been used to address overweight and obesity in men and to identify what can be learnt from this rapidly evolving field. Design Scoping review following Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for scoping review checklist for reporting. Data sources A database search was conducted using EBSCOhost (Academic Search Complete, CINAHL Complete, Global Health, Health Source: Consumer Edition, Health Source: Nursing/Academic Edition and Medline Complete), Google, Google Scholar, Open Access Theses and Dissertations platform and Scopus. Eligibility criteria All weight-loss programmes using a gender-sensitive approach to address men’s overweight and obesity in community settings. Data extraction and synthesis Narrative synthesis was conducted based on the research questions and objectives. Primary outcomes include operationalisation, context and concept of the gender-sensitive ap
Source: bmjopen.bmj.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 23
A study led by investigators from Mass Eye and Ear found that patients prescribed semaglutide (as Ozempic or Wegovy) for diabetes or weight loss had a higher risk of having a potentially blinding eye …
Source: medicalxpress.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 36GLP-1 increases preingestive satiation via hypothalamic circuits in mice and humans - 5 month(s) ago
GLP-1 receptor agonists (GLP-1RAs) are effective anti-obesity drugs. However, the precise central mechanisms of GLP-1RAs remain elusive. We administered GLP-1RAs to obese patients and observed heightened sense of preingestive satiation. Analysis of human …
Source: www.science.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 36GLP-1 increases preingestive satiation via hypothalamic circuits in mice and humans - 5 month(s) ago
GLP-1 receptor agonists (GLP-1RAs) are effective anti-obesity drugs. However, the precise central mechanisms of GLP-1RAs remain elusive. We administered GLP-1RAs to obese patients and observed heightened sense of preingestive satiation. Analysis of human …
Source: www.science.orgCategories: General Medicine News, Hem/OncsTweet
RT @BevTchangMD: 😮 In stark reversal, FDA to reconsider removal of Eli Lilly #weightloss drug from shortage list https://t.co/3Ob9BmBSJE…